Advertisement
top banner image  

topleft corner image     top right corner image
 
take action
bullet
bullet
bullet
bullet
bullet
bullet
bullet
bullet

jacc imaging image
bullet
bullet
bullet
bullet

acc links
bullet
bullet
bullet
bullet
bullet
bullet
bullet
bullet
bullet
bullet

JACC Homepage JACC Interventions Homepage
Still not a subscriber to JACC Imaging or JACC Interventions?

     top nav image

     

J Am Coll Cardiol Img, 2008; 1:221-237, doi:10.1016/j.jcmg.2008.01.011
© 2008 by the American College of Cardiology Foundation
This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by O’Gara, P.
Right arrow Articles by Vannan, M.
Right arrow Search for Related Content
PubMed
Right arrow Articles by O’Gara, P.
Right arrow Articles by Vannan, M.

The Role of Imaging in Chronic Degenerative Mitral Regurgitation

Patrick O’Gara, MD, FACC*, Lissa Sugeng, MD, FACC{ddagger}, Roberto Lang, MD, FACC{ddagger}, Maurice Sarano, MD, FACC§, Judy Hung, MD, FACC, Subha Raman, MD, FACC||, Gregory Fischer, MD{dagger}, Blasé Carabello, MD, FACC**, David Adams, MD, FACC{dagger}, Mani Vannan, MBBS, FACC||,*

* Brigham And Women’s Hospital, Boston, Massachusetts
{dagger} Mount Sinai Medical Center, New York, New York
{ddagger} University of Chicago Hospitals, Chicago, Illinois
§ Mayo Clinic, Rochester, Minnesota
Massachusetts General Hospital, Boston, Massachusetts
|| Ohio State University Medical Center, Columbus, Ohio
** Veterans Affairs Medical Center, Houston, Texas.


Figure 1
View larger version (55K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 1 Example of Mitral Valve With Type IIIb Dysfunction

The operative view is shown (left), and the corresponding "surgical view" obtained with real-time 3D transesophageal echocardiography volume rendering (right). Abbreviations: A1, A2, A3 = anterior mitral valve scallops, AL = anterolateral; P1, P2, P3 = posterior mitral valve scallops, PM = postero-medial. From Mount Sinai Medical Center and University of Chicago.

 

Figure 2
View larger version (108K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 2 Systematic Interrogation of the MV With 2D TEE

(A) 4-chamber view obtained at 0° depicting A2 on the left and P2 on the right. (B) Bicommissural view obtained by electronically rotating the transducer tip to 55° showing P3 on the left, A2 in the middle, and P1 on the right. (C) 2-chamber view obtained by rotating the transducer to 90° to visualize P3 on the left and the 3 scallops of the anterior mitral valve leaflet on the right. (D) Long-axis view obtained by further rotating the transducer to 120° to view P2 on the left and A2 on the right. The left column correspond to MV images (as visualized from the left atrial perspective) obtained with the use of real-time 3D-TEE volume rendering. Red lines represent the approximate cut planes from which the respective 2D TEE images were obtained. Ao = aorta; Lat = lateral aspect of MV; Med = medial aspect of MV; MV = mitral valve; TEE = transesophageal echocardiography; other abbreviations as in Figure 1. From Mount Sinai Medical Center and University of Chicago.

 

Figure 3
View larger version (87K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 3 Intra-Operative 2D and 3D TEE Depiction of MV Prolapse and Leaflet Flail

Schematic (upper row) and 2D as well as 3D echocardiographic examples of a patient with a normal mitral valve (left panels), mitral valve prolapse (P1, middle panels) and a flail mitral valve (P2, right panels) as visualized with 2D TEE (long-axis mid esophageal TEE views (middle row) and real-time 3D TEE volume rendering from the left atrial perspective (bottom row). The surgical views obtained with real-time 3D TEE provide unique visualization and better understanding of the anatomic relationships of the mitral valve annulus, commissures and leaflets. Abbreviations as in Figures 1 and 2.

 

Figure 4
View larger version (62K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 4 Mitral Valve Displays

(A) Anatomical view. (B) Transesophageal view (MV view as visualized in the transgastric basal short axis view. (C) Surgeon’s view. All these examples were obtained with the use of real-time 3D transesophageal echocardiography volume rendering using zoomed views. The mitral valve is visualized from the left atrial perspective. From Mount Sinai Medical Center and University of Chicago. Abbreviations as in Figure 1.

 

Figure 5
View larger version (135K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 5 Example of a Patient With a P2 Flail Mitral Valve

Examples of patients with P1 prolapse (top left); P2 flail mitral valve scallop (black arrow) with a ruptured chord (red arrow, top right); P3 flail mitral valve (black arrow, bottom left); and Barlow’s syndrome with floppy mitral valve with multiple leaflet prolapse (P1, P2 and P3) (bottom right). All images were obtained with real-time 3D-TEE volume rendering. The mitral valves are visualized from the left atrial perspective.

 

Figure 6
View larger version (134K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 6 Correlative 3-D and 2-D TEE MV Anatomy

Example of a patient with a P2 flail mitral valve. (A) Four-chamber view obtained at 0° depicting A2 on the left and P2 on the right; (B) Two-chamber view obtained by rotating the transducer to 90° to visualize P3 on the left and the 3 scallops of the anterior mitral valve leaflet on the right; (C) Long-axis view obtained by further rotating the transducer to 120° to view the flail P2 segment on the left and A2 on the right. The direction of the color jet in the long-axis view (bottom left) is away from the side of the flail lesion. The left column images correspond to the mitral valve image (as visualized from the left atrial perspective) obtained using real-time 3D-TEE volume rendering. The red arrows represent the approximate cut planes from which the respective 2D TEE images were obtained. A1, A2, A3 = scallops of the anterior mitral valve and P1, P2, P3 = scallops of the posterior mitral valve.

 

Figure 7
View larger version (81K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 7 Examples of 3D Renderings of the Mitral Valve Obtained From 3D-TEE Data Set With Software Designed for Quantitative Analysis of the Mitral Apparatus

Examples of 3D renderings of the mitral valve obtained from 3D-TEE dataset using software designed for quantitative analysis of the mitral apparatus. (Top, Left) Antero-posterior diameter is shown in green. (Top, Right) Annular height. (Bottom Left) Anterior mitral leaflet surface area (hatched) with posterior middle scallop leaflet prolapse. (Bottom, Right) Angle between the mitral and aortic annuli. A = anterior, P = posterior, AL = anterolateral, PM = posteromedial, Ao = aorta, TEE = transesophageal echocardiography.

 

Figure 8
View larger version (30K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 8 Principles of the PISA Method of MR Quantitation

The flow convergence is indicated by the large open hemisphere observed in perspective and the jet of MR by the large arrow at the bottom. V1 is the velocity on the flow convergence hemisphere (white arrows) whereas the jet velocity is V2. The right side indicates the calculation of regurgitant flow (Flow 2) and effective regurgitant orifice area (ERO). R is the radius of the hemisphere of flow convergence. MR = mitral regurgitation; PISA = proximal isovelocity surface area.

 

Figure 9
View larger version (72K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 9 Calculation of PISA Derived ERO

The left image is a zoomed view of the flow convergence zone with color-flow imaging and down-shifting of the baseline resulting in an aliasing velocity of 22 cm/s. The radius (R) of the flow convergence is measured using the 2 crosses shown and the flow is calculated at 336 ml/s. The right image shows continuous-wave Doppler measurement of the peak regurgitant velocity (MR velocity). The ERO area is calculated at 67 mm2 or 0.67 cm2, as the ratio of flow to velocity. LV = left ventricle; other abbreviations as in Figure 8.

 

Figure 10
View larger version (66K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 10 The Pathophysiologic Stages of MR

(A and B) Normal physiology (N) is contrasted with that of acute mitral regurgitation (MR). In acute MR, the volume overload of MR increases sarcomere length (SL), augmenting preload. Increased SL is reflected by an increase in end-diastolic volume (EDV). The new pathologic pathway for ejection into the left atrium (LA) reduces afterload as quantified by end-systolic stress (ESS), allowing the left ventricle to eject more completely. Enhanced ejection is reflected by a fall in end-systolic volume (ESV). As a result, the total stroke volume increases to 140 ml, but because 50% is regurgitated into the LA (regurgitant fraction [RF] 0.50), forward stroke volume (FSV) decreases. Ejection fraction (EF) increases, although contractile function (CF) is normal but not increased. (C) Chronic compensated mitral regurgitation. In this phase of MR, eccentric cardiac hypertrophy produces a further increase in EDV, which allows for a large increase in total stroke volume (190 ml) so that FSV returns to nearly normal. The enlarged and compliant LA can accommodate the regurgitant volume at a lower pressure, so that left atrial pressure declines. CF remains normal, and EF remains increased. (D) Chronic decompensated mitral regurgitation. In this phase, CF has been reduced from muscle damage caused by prolonged severe volume overload. Impaired CF reduces the effectiveness of left ventricular ejection and ESV increases. There is a further increase in diastolic volume, which is not compensatory for the increase in ESV, resulting in a decrease in total and forward stroke volumes. Concomitantly, increased EDV worsens the MR by annular dilation and papillary muscle malalignment and regurgitant fraction increases. Ejection fraction is reduced from the compensated state but often remains within the normal range.

 

Figure 11
View larger version (58K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 11 Percutaneous MV Repair Approaches

Schematic of edge-to-edge MV repair (Alfieri procedure; (top) and percutaneous mitral annuloplasty (bottom), capitalizing on the relationship between the coronary sinus and the annulus.

 

Figure 12
View larger version (60K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 12 Cardiac Computed Tomography of Coronary Sinus

(Left) Typical configuration of major cardiac veins. The volume-rendered computed tomography (CT) data show the anterior interventricular vein (AIV) draining into the great cardiac vein (GCV), which in turn becomes the coronary sinus (CS) upon receiving additional lateral vein branches. The posterior interventricular vein (PIV) is also noted. (Middle) Coronary sinus in a curved multiplanar CT format. This mode of rendering isotropic CT data allows for segmentation of the coronary sinus along its entire length (arrows). The arrowhead indicates the anterior interventricular vein. (Right) Coronary artery and coronary sinus anatomic relationship. Both the coronary sinus (arrow) and left circumflex coronary artery (arrowhead) lie in the atrioventricular groove, with the circumflex artery lying underneath the coronary sinus in this patient. The potential for myocardial ischemia induced by extrinsic compression from an overlying venous device exists. Ao = aortic valve, LV = left ventricle.

 




Advertisement
 
   
 
home link current link search link archive link topics link cardiology careers link